# Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients

> **NCT02046174** · PHASE2 · COMPLETED · sponsor: **The Rogosin Institute** · enrollment: 70 (actual)

## Conditions studied

- Colorectal Cancers

## Interventions

- **BIOLOGICAL:** RENCA macrobeads

## Key facts

- **NCT ID:** NCT02046174
- **Lead sponsor:** The Rogosin Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-03
- **Primary completion:** 2018-10-22
- **Final completion:** 2018-10-22
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02046174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02046174, "Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02046174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*